India-UK Tech Summit translates deeper ties on vaccine, anti-microbial resistance research initiatives

2016-11-07 08:57:16

At the India-UK Joint Tech Summit, Prime Minister Narendra Modi announced that the two countries will focus on new vaccines for infectious diseases and launch a new Anti-Microbial Resistance initiative with joint investment of 15 million pounds. By Team ABLEAt the ongoing India-UK Tech Summit jointly inaugurated by the Prime Minister of India Narendra Modi and the Prime Minister of United Kingdom,

Read more

ICMR calls for vaccine manufacturers to report status/details on vaccine candidates for arboviral diseases

2016-11-07 08:55:03

ICMR has announced that it would like to review the available vaccines as well as vaccine candidates for arboviral diseases prevalent or posing a threat to the Indian subcontinent .By Team ABLEIndian Council of Medical Research’s Division of Epidemiology & Communicable Diseases has called for a write up on Vaccine/Vaccine Candidates for Arboviruses. The Companies Secretary, Department of Hea

Read more

European Medicines Agency accepts to review Biocon-Mylan co-developed insulin glargine

2016-11-04 10:33:42

The European Medicines Agency (EMA) has accepted for review Mylan’s Marketing Authorization Application (MAA) for insulin glargine, which is co-developed by Biocon. By Team ABLEIndia’s leading biotechnology company Biocon and NASDAQ-listed Mylan have jointly announced that the European Medicines Agency (EMA) has accepted for review Mylan’s Marketing Authorization Application (MAA) for insuli

Read more

Safety concerns linger for generic oncology drugs in developing countries

2016-11-04 10:30:36

After analyzing safety data, International researchers have found that generic cancer drugs are generally safe in countries with rigorous regulatory programs similar to the FDA in the United States. However, in countries with less rigorous regulation, such as India, Iraq and Colombia, safety is far from certain.By Team ABLEAn international research team led by Dr Charles Bennett, Josie M Fletcher,

Read more

Advanced Enzymes acquires 70% stake in API maker JC Biotech

2016-11-04 10:14:12

This deal by Advanced Enzymes is to strengthen its leadership in API Serratiopeptidase with over 80%  market share and make a foray into biopharma and Algal DHA.By Team ABLEAdvanced Enzyme Technologies,  a  leading  specialty  biotech  company in enzymes, has entered into definitive agreements with API maker JC Biotech to acquire a 70% stake for a consideration of Rs

Read more

IIT Madras signs technology transfer agreement with SynkroMax Biotech to develop tissue engineered pericardial patch

2016-11-03 09:44:57

IIT Madras and SynkroMax Biotech have signed a technology transfer agreement for a Tissue Engineered Bovine Pericardial Patch.By Team ABLEThe Indian Institute of Technology Madras has signed a memorandum of understanding (MoU) with Chennai-based SynkroMax Biotech (SMBPL) on November 2, 2016 for a Technology Transfer. The MoU was signed by Prof. Krishnan Balasubramanian, Dean, ICSR, IIT Madras and

Read more

Biotech API manufacturing services steadily mature over chemically synthesized API manufacturing services

2016-11-03 09:43:34

A new report by TMR reveals that biotech APIs manufacturing services have high growth potential in the near future owing to increasing demand for biotechnology products.By Team ABLETransparency Market Research (TMR), a global market intelligence company providing business information reports and services, has released a new report that enlightens several dynamics in the biotechnology field that ar

Read more

Shilpa Medicare’s UK unit gets marketing authorizations for cancer drug

2016-11-03 09:42:00

Shilpa Medicare Ltd has received marketing authorizations from the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) for its cancer therapeutic Imatinib Tablets.By Team ABLEShilpa Medicare has announced that its manufacturing unit at United Kingdom has received marketing authorizations from UK MHRA for the Imatinib tablets in multiple strengths of 100 mg and 400 mg. Shilpa Medicare

Read more

Takeda takes major decisions to maintain leadership position in overseas pharma market

2016-11-03 09:40:59

Apart from Takeda being in talks to acquire Valeant Pharmaceuticals’ Salix gastrointestinal drugs business, the Japanese pharma giant has established an exclusive biotech company in the US and has also committed 1 million Yen to the Global Measles Vaccination for Children Program.By Team ABLEIn talks to buy Valeant Pharmaceuticals: Takeda is apparently on the hunt for global acquisitions after T

Read more

Biocon ranked among global top 10 biotech employers; the only Asian company to feature in 2016 rankings

2016-11-02 07:55:07

Biocon has moved up to number 9 in the ‘Science 2016 Top Employer’ ranking conducted by Science/Science Careers magazine. By Team ABLEAccording to an annual survey conducted by Science/Science Careers magazine, Asia\'s premier biopharmaceuticals company, Biocon has been ranked among the world’s top ten employers in Biotechnology. The company has moved up to number 9 in ‘Science 2016 Top Em

Read more